Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

radium-223 dichloride

- PMLiVE

France investigates Bayer’s acne drug Diane 35 after deaths

Linked to blood clots in women

- PMLiVE

AstraZeneca removes R&D and commercial heads

Pascal Soriot's leadership shake-up will see Martin Mackay and Tony Zook leave

- PMLiVE

Early 2013 sees drug filings, launches and approvals in Japan

Includes medicines from Bayer, Takeda, Astellas and Eisai

- PMLiVE

Nexavar shows promise in thyroid cancer

Potential new indication for Bayer/Onyx drug

- PMLiVE

AstraZeneca wins stay on Crestor generics in US

Appeals court upholds earlier ruling to validate patent until 2016

- PMLiVE

AstraZeneca’s fostamatinib fails to match Humira in RA

Inferiority to Abbott’s drug dents commercial prospects

- PMLiVE

Market researchers must become internal consultants

Bayer's Dr Thomas Hein gives his first interview as president of the European Pharmaceutical Market Research Association

- PMLiVE

AstraZeneca antitrust fine upheld by European Court of Justice

Lessons for pharma as landmark ruling stands

- PMLiVE

Swedish approval for Bayer’s long-term contraceptive Jaydess

Country is reference member state for approval under the decentralised EU procedure

- PMLiVE

Bayer’s eye drug Eylea approved in Europe

Will compete with Novartis' Lucentis in wet AMD

german flag

Pharma industry challenges Germany’s drug pricing policy

Says mandatory discounts and price freezes on drugs are no longer justified

- PMLiVE

India approves national drug pricing scheme

Adds around 350 new drugs to the country's essential medicines list

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links